Background L-carnitine is an essential compound that facilitates the transport of long-chain
fatty acid across the inner mitochondrial membrane for β-oxidation. However, the effect of L …

L-carnitine (LC) supplementation improves cardiac function in hemodialysis (HD) patients.
However, whether reducing LC supplementation affects carnitine kinetics and cardiac …

Abstract Background/Aim: L-Carnitine is important in β-oxidation of fatty acids. A lack of
carnitine in hemodialysis patients is caused by insufficient carnitine synthesis and especially …

Background Carnitine deficiency is common in patients on hemodialysis. However, the
efficacy of L-carnitine supplementation for improving lean body mass (LBM) and physical …

Background l-Carnitine has been used as adjuvant therapy in hemodialysis (HD) patients for
many years. However, there is controversy whether l-carnitine supplementation is beneficial …

Background. Carnitine loss through dialysis membranes is shown to be related to the lack of
carnitine in long-term haemodialysis patients. It has been previously reported that …

Abstract Background/Aims: There is a growing body of evidence that the long-term
hemodialysis (HD) treatment leads to disturbances of carnitine homeostasis but the results …

In patients on maintenance hemodialysis several factors reduce the body stored carnitine
which could lead to dyslipidemia, anemia, and general health in these patients. We …

Protein energy malnutrition and inflammation are common and usually concurrent in
maintenance hemodialysis (MHD) patients. Carnitine, a small molecule involved in fatty acid …

Objective l‐Carnitine is an endogenous molecule involved in fatty acid metabolism.
Secondary carnitine deficiency may develop in patients with end‐stage renal disease …